newsfilter
← Latest News
GlobeNewswire·

Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacy

Signed LOI to acquire a compounding pharmacy in Calgary, Alberta, Canada Valuation of approximately 3.5x TTM EBITDA of $180,000 Levitee Labs to use compounding capabilities to build its own drug brands VANCOUVER, British Columbia, Oct.